Association of Blood Inflammatory Biomarkers with Clinical Outcomes in Patients with AECOPD: An 8-Year Retrospective Study in Beijing

References

• Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195(5):557–582. doi:10.1164/rccm.201701-0218PP
   PubMed Web of Science ®Google Scholar
• Safiri S, Carson-Chahhoud K, Noori M, et al. Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990–2019: results from the global burden of disease study 2019. BMJ. 2022;378:e069679. doi:10.1136/bmj-2021-069679
   PubMed Web of Science ®Google Scholar
• Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care Med. 2001;163(5):1256–1276. doi:10.1164/ajrccm.163.5.2101039
   PubMedGoogle Scholar
• Zhang Y, Lin YX. 慢性阻塞性肺疾病急性加重住院患者一年及长期死亡风险因素分析 [Risk factors analysis for one-year and long-term mortality in patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease]. Zhonghua Jie He He Hu Xi Za Zhi. 2019;42(12):895–900. Chinese. doi:10.3760/cma.j.issn.1001-0939.2019.12.004
   PubMedGoogle Scholar
• Yao C, Liu X, Tang Z. Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD. Int J Chron Obstruct Pulmon Dis. 2017;12:2285–2290. doi:10.2147/COPD.S141760
   PubMed Web of Science ®Google Scholar
• Liu SF, Lin KC, Chin CH, et al. Factors influencing short-term re-admission and one-year mortality in patients with chronic obstructive pulmonary disease. Respirology. 2007;12(4):560–565. doi:10.1111/j.1440-1843.2007.01110.x
   PubMed Web of Science ®Google Scholar
• Patout M, Meira L, D’Cruz R, et al. Neural respiratory drive predicts long-term outcome following admission for exacerbation of COPD: a post hoc analysis. Thorax. 2019;74(9):910–913. doi:10.1136/thoraxjnl-2018-212074
   PubMed Web of Science ®Google Scholar
• Ruiz-González A, Lacasta D, Ibarz M, et al. C-reactive protein and other predictors of poor outcome in patients hospitalized with exacerbations of chronic obstructive pulmonary disease. Respirology. 2008;13(7):1028–1033. doi:10.1111/j.1440-1843.2008.01403.x
   PubMed Web of Science ®Google Scholar
• Jing Z, Chun C, Ning S, et al. Systemic inflammatory marker CRP was better predictor of readmission for AECOPD than sputum inflammatory markers. Arch Bronconeumol. 2016;52(3):138–144. doi:10.1016/j.arbres.2015.01.011
   PubMed Web of Science ®Google Scholar
• Gao S, Duan Y, Chen J, Wang J. Evaluation of blood markers at admission for predicting community acquired pneumonia in chronic obstructive pulmonary disease. COPD. 2021;18(5):557–566. doi:10.1080/15412555.2021.1976739
   PubMedGoogle Scholar
• Ding F, Liu W, Wang H, Wang W, Yang C. Guidance value of procalcitonin detection in selecting switching points for sequential therapy in patients with acute exacerbation of chronic obstructive pulmonary disease complicated by respiratory failure. Int J Chron Obstruct Pulmon Dis. 2022;17:2693–2699. doi:10.2147/COPD.S366028
   PubMed Web of Science ®Google Scholar
• Ye YP, Zhao H, Kang T, et al. Optimal cut-off value of serum procalcitonin in predicting bacterial infection induced acute exacerbation in chronic obstructive pulmonary disease: a prospective observational study. Chron Respir Dis. 2022;19:14799731221108516. doi:10.1177/14799731221108516
   Web of Science ®Google Scholar
• Wang J, Shang H, Yang X, Guo S, Cui Z. Procalcitonin C-reactive protein, PaCO2, and noninvasive mechanical ventilation failure in chronic obstructive pulmonary disease exacerbation. Medicine. 2019;98(17):e15171. doi:10.1097/MD.0000000000015171
   PubMed Web of Science ®Google Scholar
• Liu L, Luan Y, Xiao L, et al. The predictive value of serum procalcitonin for non-invasive positive pressure ventilation in the patients with acute exacerbation of chronic obstructive pulmonary disease. Medicine. 2021;100(16):e25547. doi:10.1097/MD.0000000000025547
   PubMed Web of Science ®Google Scholar
• Jimeno S, Ventura PS, Castellano JM, et al. Prognostic implications of neutrophil-lymphocyte ratio in COVID-19. Eur J Clin Invest. 2021;51(1):e13404. doi:10.1111/eci.13404
   PubMed Web of Science ®Google Scholar
• Ellingsen J, Janson C, Bröms K, et al. Neutrophil-to-lymphocyte ratio, blood eosinophils and COPD exacerbations: a cohort study. ERJ Open Res. 2021;7(4):00471–2021. doi:10.1183/23120541.00471-2021
   PubMedGoogle Scholar
• Tanrıverdi H, Örnek T, Erboy F, et al. Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD. Wien Klin Wochenschr. 2015;127(19–20):756–763. doi:10.1007/s00508-014-0690-6
   PubMed Web of Science ®Google Scholar
• Duman D, Aksoy E, Agca MC, et al. The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia. Int J Chron Obstruct Pulmon Dis. 2015;10:2469–2478. doi:10.2147/COPD.S90330
   PubMed Web of Science ®Google Scholar
• Sun W, Luo Z, Jin J, Cao Z, Ma Y. The neutrophil/lymphocyte ratio could predict noninvasive mechanical ventilation failure in patients with acute exacerbation of chronic obstructive pulmonary disease: a retrospective observational study. Int J Chron Obstruct Pulmon Dis. 2021;16:2267–2277. doi:10.2147/COPD.S320529
   PubMed Web of Science ®Google Scholar
• Luo Z, Zhang W, Chen L, Xu N. Prognostic value of neutrophil: lymphocyte and platelet: lymphocyte ratios for 28-Day mortality of patients with AECOPD. Int J Gen Med. 2021;14:2839–2848. doi:10.2147/IJGM.S312045
   PubMed Web of Science ®Google Scholar
• Kumar P, Law S, Sriram KB. Evaluation of platelet lymphocyte ratio and 90-day mortality in patients with acute exacerbation of chronic obstructive pulmonary disease. J Thorac Dis. 2017;9(6):1509–1516. doi:10.21037/jtd.2017.05.77
   PubMed Web of Science ®Google Scholar
• Alparslan BS, Tuncay E, Gungor S, et al. Can red blood cell distribution width (RDW) level predict the severity of acute exacerbation of chronic obstructive pulmonary disease (AECOPD)? Int J Clin Pract. 2021;75(11):e14730. doi:10.1111/ijcp.14730
   PubMed Web of Science ®Google Scholar
• Yilmaz G, Salihoglu Z. Does mean platelet volume/platelet count ratio and red blood cell distribution width predict in-hospital mortality in patients admitted for acute exacerbation of chronic obstructive pulmonary disease? J Immunol Clin Microbiol. 2019;4(2):18–25.
   Google Scholar
• Yao C, Wang L, Shi F, et al. Optimized combination of circulating biomarkers as predictors of prognosis in AECOPD patients complicated with heart failure. Int J Med Sci. 2021;18(7):1592–1599. doi:10.7150/ijms.52405
   PubMed Web of Science ®Google Scholar
• Zinellu A, Zinellu E, Pau MC, et al. A comprehensive systematic review and meta-analysis of the association between the neutrophil-to-lymphocyte ratio and adverse outcomes in patients with acute exacerbation of chronic obstructive pulmonary disease. J Clin Med. 2022;11(12):3365. doi:10.3390/jcm11123365
   PubMed Web of Science ®Google Scholar
• Qianqian Z, Jiachen L, Lirong L. Construction and application of data quality control system of big data integrated application platform for respiratory diseases based on electronic medical records. J Med Inform. 2022;43(7):55–60.
   Google Scholar
• Nan LB, Yin XT, Gao JP. Significant diagnostic value of free-serum PSA (FPSA)/Prostate-Specific Antigen Density (PSAD) and (F/T)/PSAD for prostate cancer of the Chinese population in a single institution. Med Sci Monit. 2019;25:8345–8351. doi:10.12659/MSM.916900
   PubMed Web of Science ®Google Scholar
• Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26(8):1364–1370. doi:10.1200/JCO.2007.12.9791
   PubMed Web of Science ®Google Scholar
• Bourdin A, Burgel PR, Chanez P, et al. Recent advances in COPD: pathophysiology, respiratory physiology and clinical aspects, including comorbidities. Eur Respir Rev. 2009;18(114):198–212. doi:10.1183/09059180.00005509
   PubMedGoogle Scholar
• Chen N, Liu S, Huang L, et al. Prognostic significance of neutrophil-to-lymphocyte ratio in patients with malignant pleural mesothelioma: a meta-analysis. Oncotarget. 2017;8(34):57460–57469. doi:10.18632/oncotarget.15404
   PubMedGoogle Scholar
• Cossu A, Budroni M, Paliogiannis P, et al. Epidemiology of thyroid cancer in an area of epidemic thyroid goiter. J Cancer Epidemiol. 2013;2013:584768. doi:10.1155/2013/584768
   PubMedGoogle Scholar
• Paliogiannis P, Fois AG, Sotgia S, et al. The neutrophil-to-lymphocyte ratio as a marker of chronic obstructive pulmonary disease and its exacerbations: a systematic review and meta-analysis. Eur J Clin Invest. 2018;48(8):e12984. doi:10.1111/eci.12984
   PubMed Web of Science ®Google Scholar
• Paliogiannis P, Fois AG, Sotgia S, et al. Neutrophil to lymphocyte ratio and clinical outcomes in COPD: recent evidence and future perspectives. Eur Respir Rev. 2018;27(147):170113. doi:10.1183/16000617.0113-2017
   PubMed Web of Science ®Google Scholar
• Teng F, Ye H, Xue T. Predictive value of neutrophil to lymphocyte ratio in patients with acute exacerbation of chronic obstructive pulmonary disease. PLoS One. 2018;13(9):e0204377. doi:10.1371/journal.pone.0204377
   PubMed Web of Science ®Google Scholar
• Liu J, Liu J, Zou Y. Relationship between neutrophil-lymphocyte ratio and short-term prognosis in the chronic obstructive pulmonary patients with acute exacerbation. Biosci Rep. 2019;39(5): BSR20190675.
   PubMedGoogle Scholar
• Rahimirad S, Ghaffary MR, Rahimirad MH, Rashidi F. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute exacerbation of chronic obstructive pulmonary disease. Tuberk Toraks. 2017;65(1):25–31. doi:10.5578/tt.27626
   PubMed Web of Science ®Google Scholar
• Emami AM, Alavi-Naeini N. Evaluation of the relationship of neutrophil-to lymphocyte ratio and platelet-to-lymphocyte ratio with in-hospital mortality in patients with acute exacerbation of chronic obstructive pulmonary disease. Clin Respir J. 2021;15(4):382–388. doi:10.1111/crj.13312
   PubMed Web of Science ®Google Scholar
• Lu FY, Chen R, Li N, et al. Neutrophil-to-lymphocyte ratio predicts clinical outcome of severe acute exacerbation of COPD in frequent exacerbators. Int J Chron Obstruct Pulmon Dis. 2021;16:341–349. doi:10.2147/COPD.S290422
   PubMed Web of Science ®Google Scholar
• Esmaeel HM, Ahmed HA. The refined ABCD assessment and non-costly laboratory parameters are outcome predictors in acute exacerbation of COPD. Egypt J Chest Dis Tuberc. 2017;66(4):599–603. doi:10.1016/j.ejcdt.2017.06.004
   Google Scholar
• Çoban AM, Aksoy E, Duman D, et al. Does eosinophilia and neutrophil to lymphocyte ratio affect hospital re-admission in cases of COPD exacerbation? Tuberk Toraks. 2017;65(4):282–290. doi:10.5578/tt.57278
   PubMedGoogle Scholar
• Dai L, Bin-Miao L, Xue-Mei O. Predictive value of neutrophil-to-lymphocyte ratio and bilirubin levels in the readmission of acute exacerbation of chronic obstructive pulmonary disease. Am J Med Sci. 2022;365(2):169–175. doi:10.1016/j.amjms.2022.05.026
   PubMed Web of Science ®Google Scholar
• Zeiger RS, Tran TN, Butler RK, et al. Relationship of blood eosinophil count to exacerbations in chronic obstructive pulmonary disease. J Allergy Clin Immunol Pract. 2018;6(3):944–954.e5. doi:10.1016/j.jaip.2017.10.004
   PubMed Web of Science ®Google Scholar
• Jabarkhil A, Moberg M, Janner J, et al. Elevated blood eosinophils in acute COPD exacerbations: better short- and long-term prognosis. Eur Clin Respir J. 2020;7(1):1757274. doi:10.1080/20018525.2020.1757274
   PubMed Web of Science ®Google Scholar
• Lu HY, Zhang R, Chang Y, et al. A structural equation model-based study on the status and influencing factors of acute exacerbation readmission of elderly patients with chronic obstructive pulmonary disease within 30 days. BMC Pulm Med. 2022;22(1):299. doi:10.1186/s12890-022-02093-w
   PubMed Web of Science ®Google Scholar
• Njoku CM, Alqahtani JS, Wimmer BC, et al. Risk factors and associated outcomes of hospital readmission in COPD: a systematic review. Respir Med. 2020;173:105988. doi:10.1016/j.rmed.2020.105988
   PubMed Web of Science ®Google Scholar
• Kendra M, Mansukhani R, Rudawsky N, et al. Decreasing hospital readmissions utilizing an evidence-based COPD care bundle. Lung. 2022;200(4):481–486. doi:10.1007/s00408-022-00548-9
   PubMed Web of Science ®Google Scholar
• Loo WK, Hasikin K, Suhaimi A, et al. Systematic review on COVID-19 readmission and risk Factors: future of machine learning in COVID-19 readmission studies. Front Public Health. 2022;10:898254. doi:10.3389/fpubh.2022.898254
   PubMed Web of Science ®Google Scholar
• Donnelly JP, Wang XQ, Iwashyna TJ, Prescott HC. Readmission and death after initial hospital discharge among patients with COVID-19 in a large multihospital system. JAMA. 2021;325(3):304–306. doi:10.1001/jama.2020.21465
   PubMed Web of Science ®Google Scholar